In vitro platform of allogeneic stem cell-derived cardiomyocyte transplantation for cardiac conduction defects

Europace. 2018 Sep 1;20(9):1553-1560. doi: 10.1093/europace/eux379.

Abstract

Aims: The aim of the present study is to develop in vitro experimental analytical method for the electrophysiological properties of allogeneic induced pluripotent stem cell-derived cardiomyocytes (CMs) in cardiac conduction defect model.

Methods and results: Cardiomyocytes were derived from rat induced pluripotent stem cells CMs (riPSC-CMs) using an embryoid body-based differentiation method with the serial application of growth factors including activin-A, bone morphogenetic protein 4 (BMP-4), and inhibitor of wnt production 2 (IWP-2). Flow cytometry analysis showed that 74.0 ± 2.7% of riPSC-CMs expressed cardiac troponin-T (n = 3). Immunostaining analysis revealed organized sarcomeric structure in riPSC-CMs and the expression of connexin 43 between riPSC-CMs and neonatal rat ventricular CMs (NRVMs). Ca2+ transient recordings revealed the simultaneous excitement of riPSC-CMs and NRVMs, and prolonged Ca2+ transient duration of riPSC-CMs as compared with NRVMs (731 ± 15.9 vs. 610 ± 7.72 ms, P < 0.01, n = 3). Isolated NRVMs were cultured in two discrete regions to mimic cardiac conduction defects on multi-electrode array dish, and riPSC-CMs were seeded in the channel between the two discrete regions. Membrane potential imaging with di-8-ANEPPS discerned the propagation of the electrical impulse from one NRVM region to the other through a riPSC-CM pathway. This pathway had significantly longer action potential duration as compared with NRVMs. Electrophysiological studies using a multi-electrode array platform demonstrated the longer conduction time and functional refractory period of the riPSC-CM pathway compared with the NRVM pathway.

Conclusion: Using an in vitro experimental system to mimic cardiac conduction defect, transplanted allogeneic riPSC-CMs showed electrical coupling between two discrete regions of NRVMs. Electrophysiological testing using our platform will enable electrophysiological screening prior to transplantation of stem cell-derived CMs.

MeSH terms

  • Action Potentials / physiology*
  • Activins / pharmacology
  • Allogeneic Cells
  • Animals
  • Animals, Newborn
  • Benzothiazoles / pharmacology
  • Bone Morphogenetic Protein 4 / pharmacology
  • Calmodulin-Binding Proteins / metabolism
  • Cardiac Conduction System Disease / therapy*
  • Cell Differentiation
  • Connexin 43 / metabolism
  • Electrophysiological Phenomena
  • Flow Cytometry
  • Heart Ventricles / cytology
  • In Vitro Techniques
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / drug effects
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / physiology*
  • Myocytes, Cardiac / transplantation
  • Rats
  • Sarcomeres
  • Transplantation, Homologous

Substances

  • Benzothiazoles
  • Bone Morphogenetic Protein 4
  • Calmodulin-Binding Proteins
  • Connexin 43
  • IWP-2 compound
  • activin A
  • Activins